Thomas Mindt

Thomas Mindt is an Associate Professor at the Department of Inorganic Chemistry, Faculty of Chemistry, and affiliated with the Joint Applied Medicinal Radiochemistry Facility. His work bridges nuclear chemistry and pharmaceutical science, focusing on radiolabeled peptides, bioconjugation strategies, and tumor-targeting probes. Key projects include bi-metallic complexes for theranostics and albumin-binding markers.

Research Interests:

• Metabolic stabilization of radiolabeled peptides
• Zirconium-89 and Lutetium-177 for nuclear imaging
• Triazole-based ligands and their pharmaceutical applications
• Albumin-binding moieties for prolonged tumor imaging

Recent Projects:

• Bi-Metallic Complexes for Synergistic-Theranostic Application (2022–2025)
• Marker für die Aktivität von Albumin-bindenden Verbindungen (2020–2024)